Literature DB >> 22535964

X-ray structures of progesterone receptor ligand binding domain in its agonist state reveal differing mechanisms for mixed profiles of 11β-substituted steroids.

Scott J Lusher1, Hans C A Raaijmakers, Diep Vu-Pham, Bert Kazemier, Rolien Bosch, Ross McGuire, Rita Azevedo, Hans Hamersma, Koen Dechering, Arthur Oubrie, Marcel van Duin, Jacob de Vlieg.   

Abstract

We present here the x-ray structures of the progesterone receptor (PR) in complex with two mixed profile PR modulators whose functional activity results from two differing molecular mechanisms. The structure of Asoprisnil bound to the agonist state of PR demonstrates the contribution of the ligand to increasing stability of the agonist conformation of helix-12 via a specific hydrogen-bond network including Glu(723). This interaction is absent when the full antagonist, RU486, binds to PR. Combined with a previously reported structure of Asoprisnil bound to the antagonist state of the receptor, this structure extends our understanding of the complex molecular interactions underlying the mixed agonist/antagonist profile of the compound. In addition, we present the structure of PR in its agonist conformation bound to the mixed profile compound Org3H whose reduced antagonistic activity and increased agonistic activity compared with reference antagonists is due to an induced fit around Trp(755), resulting in a decreased steric clash with Met(909) but inducing a new internal clash with Val(912) in helix-12. This structure also explains the previously published observation that 16α attachments to RU486 analogs induce mixed profiles by altering the binding of 11β substituents. Together these structures further our understanding of the steric and electrostatic factors that contribute to the function of steroid receptor modulators, providing valuable insight for future compound design.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22535964      PMCID: PMC3370215          DOI: 10.1074/jbc.M111.308403

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  60 in total

1.  NFkappaB selectivity of estrogen receptor ligands revealed by comparative crystallographic analyses.

Authors:  Kendall W Nettles; John B Bruning; German Gil; Jason Nowak; Sanjay K Sharma; Johnnie B Hahm; Kristen Kulp; Richard B Hochberg; Haibing Zhou; John A Katzenellenbogen; Benita S Katzenellenbogen; Younchang Kim; Andrzej Joachmiak; Geoffrey L Greene
Journal:  Nat Chem Biol       Date:  2008-03-16       Impact factor: 15.040

2.  Structural basis for agonism and antagonism for a set of chemically related progesterone receptor modulators.

Authors:  Scott J Lusher; Hans C A Raaijmakers; Diep Vu-Pham; Koen Dechering; Tsang Wai Lam; Angus R Brown; Niall M Hamilton; Olaf Nimz; Rolien Bosch; Ross McGuire; Arthur Oubrie; Jacob de Vlieg
Journal:  J Biol Chem       Date:  2011-08-17       Impact factor: 5.157

3.  A randomized, controlled trial of asoprisnil, a novel selective progesterone receptor modulator, in women with uterine leiomyomata.

Authors:  Kristof Chwalisz; Lois Larsen; Cynthia Mattia-Goldberg; Anthony Edmonds; Walter Elger; Craig A Winkel
Journal:  Fertil Steril       Date:  2007-02-20       Impact factor: 7.329

4.  A structural and in vitro characterization of asoprisnil: a selective progesterone receptor modulator.

Authors:  Kevin P Madauss; Eugene T Grygielko; Su-Jun Deng; Anthony C Sulpizio; Thomas B Stanley; Charlene Wu; Steve A Short; Scott K Thompson; Eugene L Stewart; Nicholas J Laping; Shawn P Williams; Jeffrey D Bray
Journal:  Mol Endocrinol       Date:  2007-03-13

5.  The effects of the selective progesterone receptor modulator asoprisnil on the morphology of uterine tissues after 3 months treatment in patients with symptomatic uterine leiomyomata.

Authors:  A R W Williams; H O D Critchley; J Osei; S Ingamells; I T Cameron; C Han; K Chwalisz
Journal:  Hum Reprod       Date:  2007-03-05       Impact factor: 6.918

6.  Structural characterization of the human androgen receptor ligand-binding domain complexed with EM5744, a rationally designed steroidal ligand bearing a bulky chain directed toward helix 12.

Authors:  Line Cantin; Frédérick Faucher; Jean-François Couture; Karine Pereira de Jésus-Tran; Pierre Legrand; Liviu C Ciobanu; Yvon Fréchette; Richard Labrecque; Shankar Mohan Singh; Fernand Labrie; Rock Breton
Journal:  J Biol Chem       Date:  2007-08-21       Impact factor: 5.157

Review 7.  A new generation of progesterone receptor modulators.

Authors:  Richard C Winneker; Andrew Fensome; Puwen Zhang; Matthew R Yudt; Casey C McComas; Rayomond J Unwalla
Journal:  Steroids       Date:  2008-03-28       Impact factor: 2.668

8.  Selective progesterone receptor modulators 2: use in reproductive medicine.

Authors:  Giuseppe Benagiano; Carlo Bastianelli; Manuela Farris
Journal:  Expert Opin Pharmacother       Date:  2008-10       Impact factor: 3.889

Review 9.  Selective progesterone receptor modulators 1: use during pregnancy.

Authors:  Giuseppe Benagiano; Carlo Bastianelli; Manuela Farris
Journal:  Expert Opin Pharmacother       Date:  2008-10       Impact factor: 3.889

10.  Comparative effects of SPRM asoprisnil (J867) on proliferation, apoptosis, and the expression of growth factors in cultured uterine leiomyoma cells and normal myometrial cells.

Authors:  Noriyuki Ohara; Akira Morikawa; Wei Chen; Jiayin Wang; Deborah A DeManno; Kristof Chwalisz; Takeshi Maruo
Journal:  Reprod Sci       Date:  2007-12       Impact factor: 3.060

View more
  7 in total

Review 1.  Progestin therapy to prevent preterm birth: History and effectiveness of current strategies and development of novel approaches.

Authors:  Sam A Mesiano; Gregory A Peters; Peyvand Amini; Rachel A Wilson; Gregory P Tochtrop; Focco van Den Akker
Journal:  Placenta       Date:  2019-01-28       Impact factor: 3.481

2.  Identification of ELK1 interacting peptide segments in the androgen receptor.

Authors:  Claire Soave; Charles Ducker; Seongho Kim; Thomas Strahl; Rayna Rosati; Yanfang Huang; Peter E Shaw; Manohar Ratnam
Journal:  Biochem J       Date:  2022-07-29       Impact factor: 3.766

3.  A new strategy for selective targeting of progesterone receptor with passive antagonists.

Authors:  Junaid A Khan; Abdellatif Tikad; Michel Fay; Abdallah Hamze; Jérôme Fagart; Nathalie Chabbert-Buffet; Geri Meduri; Larbi Amazit; Jean-Daniel Brion; Mouad Alami; Marc Lombès; Hugues Loosfelt; Marie-Edith Rafestin-Oblin
Journal:  Mol Endocrinol       Date:  2013-04-11

4.  Ligand induced dissociation of the AR homodimer precedes AR monomer translocation to the nucleus.

Authors:  Ryota Shizu; Kosuke Yokobori; Lalith Perera; Lee Pedersen; Masahiko Negishi
Journal:  Sci Rep       Date:  2019-11-13       Impact factor: 4.379

5.  Progesterone-targeted magnetic resonance imaging probes.

Authors:  Taryn R Townsend; Georgette Moyle-Heyrman; Preeti A Sukerkar; Keith W MacRenaris; Joanna E Burdette; Thomas J Meade
Journal:  Bioconjug Chem       Date:  2014-07-25       Impact factor: 4.774

6.  Exploring Flexibility of Progesterone Receptor Ligand Binding Domain Using Molecular Dynamics.

Authors:  Liangzhen Zheng; Valerie Chunling Lin; Yuguang Mu
Journal:  PLoS One       Date:  2016-11-08       Impact factor: 3.240

7.  EC313-a tissue selective SPRM reduces the growth and proliferation of uterine fibroids in a human uterine fibroid tissue xenograft model.

Authors:  Hareesh B Nair; Bindu Santhamma; Kalarickal V Dileep; Peter Binkley; Kirk Acosta; Kam Y J Zhang; Robert Schenken; Klaus Nickisch
Journal:  Sci Rep       Date:  2019-11-21       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.